Grey Wolf Animal HealthTSXV:WOLF 57 EBITDA Margin % is 15.78% as of Mar. 2026, which is 18% above its 10-year median of 13.36. GuruFocus rates TSXV:WOLF with a GF Score™ of 57/100 and a GF Value™ of C$1.10 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 97 Personal Services companies, Grey Wolf Animal Health ranks better than 65.98% on this metric.
Grey Wolf Animal Health (TSXV:WOLF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Grey Wolf Animal Health EBITDA Margin % Related Terms
Grey Wolf Animal Health EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:WOLF vs ROL, SCI, HRB: EBITDA Margin % Comparison
For the Personal Services subindustry, Grey Wolf Animal Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grey Wolf Animal Health EBITDA Margin % vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Grey Wolf Animal Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Grey Wolf Animal Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grey Wolf Animal Health (TSXV:WOLF) has a EBITDA Margin % of 15.78% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Grey Wolf Animal Health and its competitors. This is 18% above median its historical median of 13.36. Over the past decade, Grey Wolf Animal Health's EBITDA Margin % has ranged from 6.77 to 44.11. According to the industry distribution chart, Grey Wolf Animal Health ranks #33 out of 97 companies in the Personal Services industry, placing it in the top 34%.
Is Grey Wolf Animal Health's EBITDA Margin % too high?
Grey Wolf Animal Health's current EBITDA Margin % of 15.78% is 18% above median its 10-year median of 13.36. Over the past 10 years, this metric has ranged from a low of 6.77 to a high of 44.11. The Personal Services industry median EBITDA Margin % is 13.41. Grey Wolf Animal Health's value of 15.78% is 17.7% above this industry median. Based on the distribution chart, Grey Wolf Animal Health ranks #33 out of 97 companies in the Personal Services industry, which is above the industry midpoint. Overall, Grey Wolf Animal Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Animal Health's EBITDA Margin % compare to ROL and SCI?
According to the Personal Services industry distribution chart, Grey Wolf Animal Health ranks #33 out of 97 companies for EBITDA Margin %. This puts Grey Wolf Animal Health in the upper half of its industry. The industry median EBITDA Margin % is 13.41. Grey Wolf Animal Health's value of 15.78% is 17.7% above this benchmark. Historically, Grey Wolf Animal Health's own EBITDA Margin % has ranged from 6.77 to 44.11 over the past decade. While the company's 10-year median is 13.36 vs. the industry median of 13.41, Grey Wolf Animal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Personal Services company?
The median EBITDA Margin % among Personal Services companies is 13.41, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grey Wolf Animal Health's current EBITDA Margin % of 15.78% is 17.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Grey Wolf Animal Health and its competitors. For the Personal Services industry, the median EBITDA Margin % is 13.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grey Wolf Animal Health's current EBITDA Margin % is 15.78%, which is 18% above median its own 10-year median of 13.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Animal Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.10, compared to a current price of C$1.79 — trading 62.7% above its estimated fair value. The current EBITDA Margin % is 15.78%, which is 18% above median its 10-year median of 13.36 and 17.7% above the Personal Services industry median of 13.41. Grey Wolf Animal Health's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Grey Wolf Animal Health (TSXV:WOLF), the current EBITDA Margin % is 15.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grey Wolf Animal Health (TSXV:WOLF) Overvalued in 2026?
Based on GuruFocus' analysis, Grey Wolf Animal Health stock appears to be overvalued.
The current stock price of C$1.79 is trading 62.7% above its estimated GF Value™ of C$1.10.
GuruFocus considers Grey Wolf Animal Health to be Significantly Overvalued.
Key valuation signals for TSXV:WOLF:
EBITDA Margin %: 15.78% (18% above median its 10-year median of 13.36)
GF Value™: C$1.10 vs. price of C$1.79 (62.7% above fair value)
Industry Position: 17.7% above the Personal Services median (#33 of 97)
No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
57GF Score
Get the complete analysis for TSXV:WOLF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:WOLF has been successfully added to your 
